 |
|
Nonimmunologic targets of immunosuppressive agents in podocytes
Tae-Hyun Yoo, Alessia Fornoni
Kidney Res Clin Pract. 2015;34(2):69-75. Published online 2015 Apr 9 DOI: https://doi.org/10.1016/j.krcp.2015.03.003
|
|
Citations to this article as recorded by
 Inhibition of intrarenal PRR-RAS pathway by Ganoderma lucidum polysaccharide peptides in proteinuric nephropathy
Hui Fang, Xinxuan Li, Dongmei Lin, Lianfu Wang, Teng Yang, Baoxue Yang
International Journal of Biological Macromolecules.2023; 253: 127336. CrossRef Levamisole Modulation of Podocytes’ Actin Cytoskeleton in Nephrotic Syndrome
Susan T. Veissi, Tijmen van den Berge, Joanna A. E. van Wijk, Thea van der Velden, René Classens, Lynn Lunsonga, Rick Brockotter, Charlotte Kaffa, Sander Bervoets, Bart Smeets, Lambertus P. W. J. van den Heuvel, Michiel F. Schreuder
Biomedicines.2023; 11(11): 3039. CrossRef A critical role of the podocyte cytoskeleton in the pathogenesis of glomerular proteinuria and autoimmune podocytopathies
Qing Ye, Bing Lan, Huihui Liu, Pontus B. Persson, En Yin Lai, Jianhua Mao
Acta Physiologica.2022;[Epub] CrossRef How immunosuppressive drugs may directly target podocytes in glomerular diseases
Maurizio Salvadori, Aris Tsalouchos
Pediatric Nephrology.2022; 37(7): 1431. CrossRef Protective effects of rituximab on puromycin-induced apoptosis, loss of adhesion and cytoskeletal alterations in human podocytes
Stefanie Jeruschke, Dana Alex, Peter Friedrich Hoyer, Stefanie Weber
Scientific Reports.2022;[Epub] CrossRef Hemizygous nonsense variant in the moesin gene (MSN) leads to a new autoimmune phenotype of Immunodeficiency 50
András L. Kovács, Judit Kárteszi, Zoltán Prohászka, Tibor Kalmár, Gábor Késmárky, Katalin Koltai, Zsuzsanna Nagy, Judit Sebők, Tibor Vas, Krisztián Molnár, Tímea Berki, Katalin Böröcz, Csaba Gyömörei, József Szalma, Miklós Egyed, Szabina Horváth, Péter Ol
Frontiers in Immunology.2022;[Epub] CrossRef Defining diagnostic trajectories in patients with podocytopathies
Luigi Cirillo, Gianmarco Lugli, Valentina Raglianti, Fiammetta Ravaglia, Elisa Buti, Samuela Landini, Francesca Becherucci
Clinical Kidney Journal.2022; 15(11): 2006. CrossRef An updated view of the pathogenesis of steroid-sensitive nephrotic syndrome
Tomoko Horinouchi, Kandai Nozu, Kazumoto Iijima
Pediatric Nephrology.2022; 37(9): 1957. CrossRef Beneficial effects of procyanidin B2 on adriamycin-induced nephrotic syndrome mice: the multi-action mechanism for ameliorating glomerular permselectivity injury
Chuanping Zhao, Jiamei Tang, Xiaoya Li, Zihan Yan, Liangliang Zhao, Wenbo Lang, Chunmao Yuan, Chengyan Zhou
Food & Function.2022; 13(16): 8436. CrossRef Therapeutic trials in adult FSGS: lessons learned and the road forward
An S. De Vriese, Jack F. Wetzels, Richard J. Glassock, Sanjeev Sethi, Fernando C. Fervenza
Nature Reviews Nephrology.2021; 17(9): 619. CrossRef A Rare Autosomal Dominant Variant in Regulator of Calcineurin Type 1 (RCAN1) Gene Confers Enhanced Calcineurin Activity and May Cause FSGS
Brandon M. Lane, Susan Murray, Katherine Benson, Agnieszka Bierzynska, Megan Chryst-Stangl, Liming Wang, Guanghong Wu, Gianpiero Cavalleri, Brendan Doyle, Neil Fennelly, Anthony Dorman, Shane Conlon, Virginia Vega-Warner, Damian Fermin, Poornima Vijayan,
Journal of the American Society of Nephrology.2021; 32(7): 1682. CrossRef Drug-Induced Nephrotoxicity Assessment in 3D Cellular Models
Pengfei Yu, Zhongping Duan, Shuang Liu, Ivan Pachon, Jianxing Ma, George Hemstreet, Yuanyuan Zhang
Micromachines.2021; 13(1): 3. CrossRef CD80 Insights as Therapeutic Target in the Current and Future Treatment Options of Frequent-Relapse Minimal Change Disease
Yoong Mond Teh, Soo Kun Lim, Norhana Jusoh, Kahar Osman, Siti Aisyah Mualif, Nisreen Abu Shahin
BioMed Research International.2021; 2021: 1. CrossRef Podocytopathies
Jeffrey B. Kopp, Hans-Joachim Anders, Katalin Susztak, Manuel A. Podestà, Giuseppe Remuzzi, Friedhelm Hildebrandt, Paola Romagnani
Nature Reviews Disease Primers.2020;[Epub] CrossRef Modern pharmacological approaches to primary treatment nephrotic syndrome
Ya. F. Zverev, A. Ya. Rykunova
Nephrology (Saint-Petersburg).2020; 24(4): 9. CrossRef Levamisole in Children with Idiopathic Nephrotic Syndrome: Clinical Efficacy and Pathophysiological Aspects
Anne K. Mühlig, Jun Young Lee, Markus J. Kemper, Andreas Kronbichler, Jae Won Yang, Jiwon M. Lee, Jae Il Shin, Jun Oh
Journal of Clinical Medicine.2019; 8(6): 860. CrossRef Treatment and clinical outcomes of elderly idiopathic membranous nephropathy: A multicenter cohort study in Korea
Eunjin Bae, Sung Woo Lee, Seokwoo Park, Dong Ki Kim, Hajeong Lee, Hyuk Huh, Ho Jun Chin, Shina Lee, Dong-Ryeol Ryu, Ji In Park, Sejoong Kim, Dong Jun Park, Shin-Wook Kang, Yon Su Kim, Yun Kyu Oh, Yong Chul Kim, Chun Soo Lim, Jung Tak Park, Jung Pyo Lee
Archives of Gerontology and Geriatrics.2018; 76: 175. CrossRef ACTH action on podocytes: mystery solved?
Paolo Cravedi, Kirk N. Campbell
American Journal of Physiology-Renal Physiology.2016; 310(11): F1178. CrossRef Characterization of the myoepithelial cells in the major salivary glands of the fruit bat Artibeus jamaicensis
Julio Guerrero‐Hernández, Norma Moreno‐Mendoza
Journal of Anatomy.2016; 229(2): 302. CrossRef Melanocortin 1 receptor agonist protects podocytes through catalase and RhoA activation
Johannes Elvin, Lisa Buvall, Annika Lindskog Jonsson, Anna Granqvist, Emelie Lassén, Lovisa Bergwall, Jenny Nyström, Börje Haraldsson
American Journal of Physiology-Renal Physiology.2016; 310(9): F846. CrossRef Organ-on-a-chip and the kidney
Sejoong Kim, Shuichi Takayama
Kidney Research and Clinical Practice.2015; 34(3): 165. CrossRef
|